Literature DB >> 26598393

Acute myeloid leukemia--major progress over four decades and glimpses into the future.

Hagop Kantarjian1.   

Abstract

In this Review, the progress in research and therapy of acute myeloid leukemia is detailed.
© 2015 Wiley Periodicals, Inc.

Entities:  

Mesh：

Year:  2016        PMID： 26598393     DOI： 10.1002/ajh.24246

Source DB:  PubMed          Journal:  Am J Hematol        ISSN： 0361-8609            Impact factor:   10.047


  37 in total

Review 1.  Echinocandin prophylaxis in patients undergoing haematopoietic cell transplantation and other treatments for haematological malignancies.

Authors:  David J Epstein; Susan K Seo; Janice M Brown; Genovefa A Papanicolaou
Journal:  J Antimicrob Chemother       Date:  2018-01-01       Impact factor: 5.790

2.  Randomized trial comparing standard vs sequential high-dose chemotherapy for inducing early CR in adult AML.

Authors:  Renato Bassan; Tamara Intermesoli; Arianna Masciulli; Chiara Pavoni; Cristina Boschini; Giacomo Gianfaldoni; Filippo Marmont; Irene Cavattoni; Daniele Mattei; Elisabetta Terruzzi; Lorella De Paoli; Chiara Cattaneo; Erika Borlenghi; Fabio Ciceri; Massimo Bernardi; Anna M Scattolin; Elisabetta Todisco; Leonardo Campiotti; Paolo Corradini; Agostino Cortelezzi; Dario Ferrero; Pamela Zanghì; Elena Oldani; Orietta Spinelli; Ernesta Audisio; Sergio Cortelazzo; Alberto Bosi; Brunangelo Falini; Enrico M Pogliani; Alessandro Rambaldi
Journal:  Blood Adv       Date:  2019-04-09

Review 3.  Future prospects of therapeutic clinical trials in acute myeloid leukemia.

Authors:  Maliha Khan; Armaghan-E-Rehman Mansoor; Tapan M Kadia
Journal:  Future Oncol       Date:  2016-10-24       Impact factor: 3.404

4.  Heterogeneity in refractory acute myeloid leukemia.

Authors:  Sachi Horibata; Gege Gui; Justin Lack; Christin B DeStefano; Michael M Gottesman; Christopher S Hourigan
Journal:  Proc Natl Acad Sci U S A       Date:  2019-05-07       Impact factor: 11.205

Review 5.  The cure of leukemia through the optimist's prism.

Authors:  Hagop M Kantarjian; Nitin Jain; Guillermo Garcia-Manero; Mary Alma Welch; Farhad Ravandi; William G Wierda; Elias J Jabbour
Journal:  Cancer       Date:  2021-10-06       Impact factor: 6.860

6.  Therapeutic vaccination with 4-1BB co-stimulation eradicates mouse acute myeloid leukemia.

Authors:  Daniel Kerage; Megan S F Soon; Brianna L Doff; Takumi Kobayashi; Michael D Nissen; Pui Yeng Lam; Graham R Leggatt; Stephen R Mattarollo
Journal:  Oncoimmunology       Date:  2018-07-26       Impact factor: 8.110

7.  A retrospective study of the correlation of in vitro chemosensitivity using ATP-TCA with patient clinical outcomes in acute myeloid leukemia.

Authors:  Fan Xia; Sheng Ma; Yicong Bian; Di Yu; WenXia Ma; Miao Miao; Chenrong Huang; Liyan Miao
Journal:  Cancer Chemother Pharmacol       Date:  2019-10-25       Impact factor: 3.333

8.  Knockout Of BIRC5 Gene By CRISPR/Cas9 Induces Apoptosis And Inhibits Cell Proliferation In Leukemic Cell Lines, HL60 And KG1.

Authors:  Manizheh Narimani; Mohammadreza Sharifi; Ali Jalili
Journal:  Blood Lymphat Cancer       Date:  2019-11-27

Review 9.  New Treatment Options for Older Patients with Acute Myeloid Leukemia.

Authors:  Kapil Saxena; Marina Konopleva
Journal:  Curr Treat Options Oncol       Date:  2021-03-20

10.  HCK maintains the self-renewal of leukaemia stem cells via CDK6 in AML.

Authors:  Zheng Li; Fangce Wang; Xiaoxue Tian; Jun Long; Bin Ling; Wenjun Zhang; Jun Xu; Aibin Liang
Journal:  J Exp Clin Cancer Res       Date:  2021-06-24
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.